Skip to content
★ Sign in to follow
한독

한독 Stock: price and insider trades · South Korea

KR·Mcap ₩106.7BHealth Care

No insider purchase over the last 90 days. The latest, by 와이앤에스인터내셔날, was filed 04 Jun 2026.

한독: what insiders have been doing

This page follows insider dealings at 한독 as filed with DART (FSS), a company from the Health Care sector. In the past year (2 November 2025 to 2 November 2026), 8 filings came from 4 insiders.

Open-market activity splits into 3 purchases totalling €282k and 1 sale; 2 insiders sit on the buying side and 1 insider on the selling side. No amount is published for 3 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. One trade stands out by size: a purchase of €282k from 와이앤에스인터내셔날, disclosed on 4 June 2026. On the buying side, the filings list 1 senior executive among the declarants.

The latest purchase dates back some time: it was published 157 days ago, on 4 June 2026. Typically, a trade is published a median of 7 days after it takes place. Until a filing is published, the market cannot know about the trade.

Compared with its exchange (2,655 companies, median 7 filings), a count of 8 filings is above the norm. Over the whole record (from 2021), the tally stands at 7 purchases and 1 sale.

Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and UCB. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.

Insider Decl.
27
Thresholds
n/a
Buy Volume
€293,909
7 ops. · all time
Sell Volume
€733,565
1 ops. · all time

Who traded when

BuySale
이동국2 buys
김영진1 sale
아이비케이캐피탈1 buy
와이앤에스인터내셔날1 buy

Since the insiders bought

  • Filed 04 Jun 2026 · 157 days ago · €282k
    +1.0%
    Entry ₩8,130 · Close 30 Oct 2026 ₩8,210
  • Filed 13 Mar 2026 · 240 days ago · €6,439
    -23.3%
    Entry ₩10,700 · Close 30 Oct 2026 ₩8,210

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 23,159 of 26,897 companies
25.6
score / 100
Value
26
Quality
25
FCF yld-11%
Earn yld-2.0%
EV/EBITDA13.7x
ROE-3.7%
Gross mgn30%
Net mgn-0.4%
Debt/EBITDA10.7x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩8,210
Analyst consensus
·
Income statement
Revenue₩535.1B
Gross profit₩158.9B30% margin
EBITDA₩35.5B7% margin
Net income-₩2.2B-1.7% margin
Valuation
Beta0.18
Balance sheet & cash
Market cap₩106.7B
Total debt₩378.6B
Free Cash Flow-₩11.9B
Debt / Equity148%
Profitability & ownership
ROE-3.7%
ROA0.7%
% insiders42.2%
% institutions0.4%
Last declaration on 18 June 2026
Declarations33 total
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ▼
    대량보유자Executives
    €734kest.0DART
    170,028 sharesKRXDART:20260604000318
  • ▲
    Executives
    499M KRW10DART
    56,676 shares@ ₩8,800.00100.0% of flowShareKRXDART:20260604000304
    Canonical exit: 30 Aug 2026 (T+90)
  • ▲
    상무Executives(filed)
    €5,229est.0DART
    1,000 sharesShareKRXDART:20260519000023
    Canonical exit: 17 Aug 2026 (T+90)
  • ▲
    상무Executives
    €6,439est.0DART
    1,000 sharesShareKRXDART:20260313000270
    Canonical exit: 1 Jun 2026 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives
    0DART
  • ●
    Executives
    0DART
    0KRXDART:20241227000051
  • ▲
    Related company / holdingExecutives
    0DART
    2,338,269 sharesKRXDART:20241216000213
    Canonical exit: 13 Mar 2025 (T+90)
  • ●
    Executives
    0DART
    0KRXDART:20240701000200
  • ●
    Executives
    0DART
    0KRXDART:20231005000089
  • ●
    Executives
    0DART
    0KRXDART:20230703000201
  • ▲
    상무Executives(filed)
    0DART
    ShareKRXDART:20230331002394
    Canonical exit: 29 Jun 2023 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives(filed)
    0DART
    0KRXDART:20221228000144
  • ●
    Executives(filed)
    0DART
    0KRXDART:20221006000443
  • ●
    Executives(filed)
    0DART
    0KRXDART:20220816000084
  • ●
    Executives(filed)
    0DART
    0KRXDART:20220707000083

25 of 33 declarations

About 한독

HanDoc is a company in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the development and distribution of pharmaceutical products.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations